Press - MIG Verwaltung EN

Münchner Merkur - Wed, 14. April 2021

How to bring buildings into a computer

„Münchner Merkur“ portrays NavVis, a MIG-portfolio company.

Manager Magazin - Fri, 02. April 2021

Quantum Computing – it starts to be serious

A podcast of „Manager Magazin“ explains the state of the art of Quantum Computing and mentions MIG portfolio company IQM as a leading player and Michael Motschmann, General Partner MIG AG, as investor.

Find out more

Manager Magazin - Wed, 24. March 2021

Biontech Investors put on Quantum Computing

„Manager Magazin Online“ reports about the assignment of Helmut Jeggle as Member of the Supervisory Board of IQM. The article mentions MIG Fonds and Michael Motschmann, Gneneral Partner of MIG AG, as first investor of the Finnish-German Start-up in Quantum Computing.

Find out more

Süddeutsche Zeitung - Sun, 21. March 2021

Super Quanten

„Süddeutsche Zeitung“ reports about an innovative Quantum Computing Project of Leibnitz Rechenzentrum (LRZ) in Garching/Munich integrating IQM, a MIG portfolio company.

Find out more

VC Magazin - Sun, 21. March 2021

„Investors got their money seven times back“

Interview with Michael Motschmann, General Partner of MIG AG, in „VC-Magazin“ about the investment in BioNTech

Find out more

Manager Magazin - Sat, 20. March 2021

Going viral

In an article about the German Biotech Industry „Manager Magazin“ quotes Dr. Matthias Kromayer, General Partner of MIG AG.

DIE WELT - Thu, 18. March 2021

„What in Germany is possible“ and „The Heroes of the German Vaccine Fairy Tale“

„DIE WELT“ describes the development of MIG portfolio company BioNTech und the founders. The article refers to the role of Michael Motschmann and Dr. Matthias Kromayer, General Partner of MIG AG. Additionally an interview in „DIE WELT“ with Michael Motschmann.

Find out more

Handelsblatt - Wed, 17. March 2021

Six Start-ups are the German Hope in Quantum Computing

„Handelsblatt“ mentions IQM, a MIG portfolio company, as one of the leading German start-ups in Quantum Computing

Find out more

Börse Online - Thu, 11. March 2021

Success with molecules

In an article about Biotech IPOs in the US, „Börse Online“ quotes Dr. Matthias Kromayer, General Partner MIG AG.

Find out more

Wirtschaftswoche - Fri, 05. March 2021

The next enemy will be tougher

„Wirtschaftswoche“ explains the future of MIG portfolio company BioNTech with quotes of Michael Motschmann, General Partner MIG AG.

Find out more

Handelsblatt - Wed, 03. March 2021

Serious deficits

Angela Merkel and other heads of government claim a digital pact. Dr. Jan Goetz, CEO of MIG portfolio company IQM, calls for an European approach to Quantum Computing.

Find out more

BioCentury - Mon, 01. March 2021

The dark of COVID-19 brings promise to Germany´s biotech scene

Trade publication „BioCentury“ quotes Michael Motschmann, General Partner of MIG AG, in an article about the future of German Biotech industry.

Find out more

Tagesschau.de - Sat, 27. February 2021

Many ideas, little money

„tagesschau.de“ reports about investments in Biotech in Germany and quotes Michael Motschmann, General Partner MIG AG.

Find out more

Finanzwelt, VC Magazin - Wed, 24. February 2021

Next MIG Invest in Medical Technology

Several Trade Magazines report about MIGs investment in new portfolio company Creative Balloons.

Find out more

CHEManager - Wed, 17. February 2021

The Deals of German Biotech Investors

Trade Magazin „CHEManager“ reports about German Investors in Biotech, among them MIGs investments.

Find out more

Börsen Zeitung - Fri, 12. February 2021

Record return for MIG because of Biontech

„Börsen Zeitung“ interviews Michael Motschmann, General Partner of MIG AG, about new developments at MIG

Finanzwelt - Fri, 12. February 2021

MIG Fonds expand in the French Alps

„Finanzwelt“ reports about a new investment of MIG Fonds in Zadient Technologies.

Find out more

Financial Times, Reuters, Manager Magazine et al - Thu, 04. February 2021

BioNTech Fund (MIG) pays 600m Euro dividend on back of vaccine success

International and national media among them „Financial Times“ and „Reuters“ report about the record payment of MIG Fonds of 600m Euro to investors.

Find out more

Manager Magazin - Fri, 29. January 2021

Everything started with a dream

„Manager Magazin“ interviews Michael Motschmann, General Partner of MIG AG, and Co-Investors Thomas Strüngmann and Helmut Jeggle about their joint involvement at BioNTech SE.

Find out more

Handelsblatt - Thu, 14. January 2021

Exosceletts reduce sick days

„Handelsblatt“ reports about the technology of GBS, a start-up producing exosceletts; MIG Fonds invested recently.

Find out more

Frankfurter Allgemeine Zeitung - Sat, 09. January 2021

Screen Supplier to sell

„FAZ“ reports about the start of a trade sale of Cynora, a portfolio company of MIG Fonds.

Süddeutsche Zeitung - Wed, 23. December 2020

Express

„Süddeutsche Zeitung“ describes how BioNTech developed in a very short period the vaccine against Covid-19 and marks Michael Motschmann, General Partner of MIG AG, as one of the first investors of BioNTech.

Find out more

Financial Times - Wed, 16. December 2020

FT People of the Year: BioNTech´s Ugur Sahin and Özlem Türeci

„Financial Times“ chooses BioNTech´s Ugur Sahin and Özlem Türeci as „People of the Year“. In a cover story MIG AG is described as a first investor and Matthias Kromayer, General Partner of MIG AG, is quoted.

Find out more

Techcrunch; goingpublic.de - Mon, 14. December 2020

German Bionic raises $20 M led by Samsung for exoskeleton tech to supercharge human labor

„Techcrunch“ and other media report about a Series A-Financing of German Bionic Systems by MIG Fonds and other investors.

Find out more

Bloomberg - Sun, 13. December 2020

Bloomberg prognosis, 13. Dezember 2020, First Covid Vaccines´ Triumph Raises Hope for Cancer Fight

„Bloomberg prognosis“ explains how mRNA vaccines against Covid-19 raises hope in the fight against cancer, with quotes of Dr. Matthias Kromayer, General Partner of MIG AG.

Find out more

Tagesschau.de - Sat, 05. December 2020

The couple behind the vaccine against Covid-19

„Tagesschau.de“ portrays Özlem Türeci and Ugur Sahin, the founder of MIG-portfolio company BioNTech, and quotes Michael Motschmann, General Partner of MIG AG.

Find out more

Handelsblatt - Fri, 04. December 2020

From Biontech to Sputnik V

Dr. Matthias Kromayer, General Partner MIG AG, explains in a byline article for „Handelsblatt“ the differencies between the vaccines against Covid-19.

Find out more

Handelsblatt - Fri, 04. December 2020

Start-up Konux gets a large order from Deutsche Bahn

„Handelsblatt“ reports about a large order of Deutsche Bahn to Konux, a MIG Portfolio company.

Find out more

Bayerische Staatszeitung - Fri, 04. December 2020

Competition for the Super-Brain

„Bayerische Staatszeitung“ explains the development of Quantum Computing and reports about IQM, a MIG portfoliocompany.

Find out more

Frankfurter Allgemeine Zeitung - Wed, 02. December 2020

Great Britain approves vaccine of Biontech and Pfizer against Covid 19

Like other media around the globe „FAZ“ reports about the first approval of Biontechs vaccine against Covid-19.

Find out more

Going Public; finanzwelt; tech.eu - Wed, 25. November 2020

MIG Fonds invests in Innatera

Several Media report about investment of MIG Fonds in new portfolio company Innatera

Find out more

DIE ZEIT - Fri, 20. November 2020

Application for admission of Corona vaccine submitted

„DIE ZEIT“ reports like many other media around the globe that MIG portfolio company BioNTech together with Pfizer submitted the application for admission of their Covid-19 vaccine at FDA .

Find out more

Frankfurter Allgemeine Sonntagszeitung - Sun, 15. November 2020

The Billionaires behind the Vaccine

„FAS“ describes the engagement of BioNTech investors Andreas and Thomas Strüngmann and the role of Michael Motschmann, General Partner of MIG AG, financing the firm from Mainz.

Find out more

Süddeutsche Zeitung - Sat, 14. November 2020

„Never in my career I met such a brilliant couple“

Michael Motschmann, General Partner of MIG AG, and Thomas Strüngmann explain in an interview with „Süddeutsche Zeitung“ their relationship as investors to BioNTech founders Prof. Dr. Ugur Sahin and Özlem Türeci.

Find out more

Handelsblatt - Fri, 13. November 2020

Founder couple from Mainz develops vaccine against corona

In a title story „Handelsblatt“ portrays the founder of BioNTech und mentions the role of Michael Motschmann, General Partner of MIG AG, as first investor

Find out more

Handelsblatt - Wed, 11. November 2020

IQM Hope in Quantum Computing

German business newspaper „Handelsblatt“ portrays MIG portfolio company IQM in a comprehensive article as hope of the European Quantum Computing Industry.

Find out more

The Times - Tue, 10. November 2020

Vaccine milestone heralds „normal life“ by next spring

The breaking news about important steps toward a vaccine against Covid-19 causes, that newspapers around the world like „The Times“ report about the founders of BioNTech, a MIG portfolio company, on their frontpages.

Find out more

Gruenderszene, Venturebeat, tech.eu, Siliconcanal - Tue, 10. November 2020

MIG Fonds lead financing round at IQM

Several media report a 36 Mio. Euro financing round at IQM Quantum Computing led by MIG Fonds.

Find out more

Handelsblatt - Tue, 10. November 2020

The Start-up of Gloria Seibert shaped the market in an early stage

„Handelsblatt“ explains in a comprehensive article the business model of Temedica and mentions MIG Fonds as investor.

Find out more

Reuters - Mon, 09. November 2020

Behind Pfizer´s vaccine, an understated husband-and-wife „dream team"

Newswire „Reuters“ is portraying the couple behind BioNTech with quotes of Dr. Matthias Kromayer, General Partner MIG AG and for many years member of the supervisory board of BioNTech.

Find out more

Frankfurter Allgemeine Zeitung - Mon, 09. November 2020

Corona-Vaccine of BioNTech effective in over 90 percent of cases

MIG-portfolio company BioNTech und partner Pfizer are announcing important improvements of their vaccine against Covid-19. Media around the world are reporting, among them „FAZ“.

Find out more

Handelsblatt - Mon, 12. October 2020

If the digital consultant cares about your finance

reports about digital platforms in the finance industry and mentions wealthpilot, a MIG portfolio company.

Find out more

Frankfurter Allgemeine Zeitung - Mon, 05. October 2020

IPolitics should stay away

In an interview with „FAZ“ Pfizer´s top executive Kathrin Jansen explains the cooperation with BioNTech, a MIG portfolio company, in the search for a vaccine against Covid-19

Find out more

Frankfurter Allgemeine Sonntagszeitung - Sun, 04. October 2020

We get close to the target

Prof. Dr. Ugur Sahin, CEO of MIG portfolio company BioNTech, explains in an interview with „FAS“ the state of the art of the development of a vaccine against Covid-19.

Frankfurter Allgemeine Sonntagszeitung - Sun, 04. October 2020

The Munich Start-up factory

An article in „FAS“ describes Technische Universität München (TUM) as excellent incubator of start-ups with quotes of Dr. Axel Thierauf, Venture Partner of MIG AG, about MIG portfolio companies with origin at TUM.

FAZ - Thu, 01. October 2020

Golden Rain at Nasdaq

Quote of Dr. Matthias Kromayer in an article of „Börse Online“ about IPOs of Biontech companies at Nasdaq.

Life Science - Wed, 30. September 2020

We were convinced early about the IPO plans of Immatics

Interview with Dr. Matthias Kromayer, General Partner MIG AG, about the IPO of our portfolio company Immatics. .

Find out more

Frankfurter Rundschau - Wed, 23. September 2020

How a Start-up tries to avoid deadly infections in clinics

In a portray of MIG portfolio company GWA Hygiene GmbH newspaper „Frankfurter Rundschau“ explains the business model of the firm.

Find out more

Capital Heft Oktober - Wed, 23. September 2020

Quantum Advantage

In a detailed story business magazine „Capital“ presents start-up IQM from Finland, a MIG portfolio company, as a leading european firm in the sector of Quantum Computing.

DIE WELT - Mon, 07. September 2020

The new Spirit of equal Opportunities

German Newspaper „DIE WELT“ portrays Gloria Seibert, founder of MIG portfolio company Temedica.

Find out more

Der SPIEGEL - Sat, 22. August 2020

Comeback of Plastics

The magazine „SPIEGEL“ points out the USP of MIG portfolio company APK in the recycling of plastics.

Handelsblatt - Thu, 20. August 2020

Enormous demand

„Handelsblatt“ decribes the market for vaccines against Covid 19. The potential revenues in the first phase could be around 20 Billion US Dollar for firms like BioNTech, a portfolio company of MIG Fonds.

Find out more

Handelsblatt - Thu, 02. July 2020

Biotech-Firm Immatics from Tübingen with Nasdaq Listing

„Handelsblatt.com“ reports about the Listing of MIG-portfolio company Immatics at New Yorks Nasdaq.

Find out more

FOCUS - Thu, 02. July 2020

Biontech Vaccine: Good data creat hope in turnaround

„Focus“ and other media report about good results of BioNTech, a MIG portfolio company, in search of a vaccine against Covid-19.

Find out more

Manager Magazin - Mon, 29. June 2020

Singapurs Funds Temasek invests in BioNTech

„Manager Magazin“ reports about a 250 million investment of Temasek in BioNTech, a MIG portfolio company.

Find out more

FAZ - Mon, 15. June 2020

„It´s not a question to participate in a race“

„Süddeutschen Zeitung“ interviews Prof. Dr. Ugur Sahin, CEO of MIG portfolio company BioNTech, about the state of the art in developing a vaccine against Covid-19.

Find out more

FOCUS, Heft 23/2020 - Sat, 30. May 2020

The next quantum leap

In an article in detail „Focus“ describes the state of the art of quantum computing in Europe and mentions MIG portfolio company IQM as a main player.

Focus - Fri, 15. May 2020

Costs nothing, not destroyable

Magazine „Focus“ reports, how Airbus will beat Boing with new materials from Amsilk, a MIG-portfolio company.

Find out more

EU-Startups - Thu, 14. May 2020

10 promising European deeptech startups leading us into the future

Platform „EU-Startups“ provides an overview of European „deeptech startups“ and highlights MIG-portfolio company IQM and the founder Dr. Jan Goetz.

Find out more

Manager Magazin - Thu, 14. May 2020

Biontech expects first data til July in their development of a vaccine against Covid-19

Several media reports new steps of BioNTech, a MIG portfolio company, in search of a vaccine against the new Coronavirus.

Find out more

Gründerszene - Wed, 13. May 2020

The start-up of this German build hardware for Quantumcomputers

„Gründerszene“ portrays Dr. Jan Goetz, CEO of IQM, a MIG portfolio company.

Find out more

Tagesschau, FAZ and other media - Wed, 22. April 2020

First clinical study for a Corona-Vaccine in Germany approved

FAZ and other media report, that in Germany for the first time a clinical study got the approval to test a Corona-Vaccine. MIG-Portfolio company BioNTech is allowed to start tests of his vaccine with volunteers.

Find out more

Handelsblatt - Thu, 09. April 2020

Biontech and Pfizer are planning to produce millions of units of Corona-vaccine this year

Handelsblatt.com reports about the plans of BioNTech, a portfolio company of MIG Fonds, to develop and produce a vaccine against Covid-19 together with Pfizer.

Find out more

Manager Magazin - Tue, 31. March 2020

Power-Paar against SARS-CoV-2

„Manager Magazin Online“ portrays Ugur Sahin and Özlem Türeci of BioNTech and acknowledge the role of MIG Fonds in founding and financing the firm.

Find out more

DIE ZEIT - Wed, 25. March 2020

Saving the World

Weekly Magazine „DIE ZEIT“ reports about pharmaceutical companies searching for vaccines against SARS CoV-2 focusing on BioNTech, a MIG portfolio company.

Find out more

Going Public Media - Sat, 21. March 2020

AFFiRiS erhält Patent für Parkinson-Medikament in China

„Going Public“ reports about progresses of MIG portfolio company AFFiRiS. The biotech firm, based in Vienna, got a patent in China and will start a clinical study (Parkinson) in the second half of the year.

Find out more

Financial Times - Fri, 20. March 2020

Ugur Sahin : the immunologist racing to find a vaccine

„Financial Times“ portrays Prof. Dr. Ugur Sahin, CEO of MIG portfolio company BioNTech, who started the race to find the first vaccine against SARS CoV-2.

Find out more

transkript, Finanzwelt und andere - Wed, 18. March 2020

Immatics is planning a listing on the Nasdaq

Several national and international media are reporting about the IPO-plans of MIG portfolio company Immatics in Q2. on the Nasdaq.

Find out more

Reuters, Handelsblatt, FAZ - Mon, 16. March 2020

BioNTech in China alliance with Fosun over coronavirus vaccine candidate

Newswire „Reuters“ reports about a cooperation of BioNTech, a MIG portfolio company. Together with Fosun Pharmaceutical a vaccine against Covid-19 should be developed first in China.

Find out more

Life Science - Sun, 15. March 2020

The IPO took BioNTech onto the international stage

„Life Sciences“ is interviewing Sierk Pötting, BioNTech SE, and Michael Motschmann, General Partner der MIG AG, about the success of BioNTech.

Mehr erfahren

Reuters - Fri, 06. March 2020

Pfizer weighs working with BioNTech on potential coronavirus vaccine

Reuters reports, that Pfizer weighs working with MIG portfolio company BioNTech on a potential coronavirus vaccine.

Find out more

Finanzwelt - Wed, 04. March 2020

Third Investment of MIG 16

Trade magazine „Finanzwelt“ reports about MIG Fonds newest investment in Neracare GmbH.

Find out more

OLED Brief - Tue, 03. March 2020

Cynora introduces fluorescent blue emitter

Trade magazine „OLED-Brief“ reports about the first commercial OLED-product of Cynora, a MIG portfolio company.

Find out more

transkript - Thu, 20. February 2020

Immatics closes second TCR-T-Billion Deal

Trade Magazine „transkript“ reports about a deal between immatics, a MIG porfolio company, and GlaxoSmithKline, which assures immatics milestone payments up to 1.1 Billion US Dollar.

Find out more

Finanzwelt - Tue, 11. February 2020

„We align our portfolio along trends of the future“

„Finanzwelt“ reports about the year 2019 of MIG AG.

Find out more

Gründerszene - Wed, 29. January 2020

„For me it would not be enough to sell shoes online“

Interview with Gloria Seibert, founder of Temedica, a new MIG portfolio company.

Find out more

transkript - Mon, 20. January 2020

Advancecor achieves good data of Revacept

Trade magazine „transkript“ reports about a successful phase-II-study of biontech-firm AdvanceCOR, a MIG portfolio company.

Find out more

Wirtschaftswoche, Munich Start-up, Going Public Media, kma, Gründerszene - Tue, 14. January 2020

Series B Funding of Temedica

Several media report about the 17 million Euro series-B-financing round of Temedica, which was led by MIG Fonds.

Find out more

Venturebeat - Mon, 30. December 2019

IQM CEO: Europe could lead the quantum computing revolution.

„Venturebeat“ interviews Dr. Jan Goetz, CEO of MIG portfolio company IQM. Dr. Goetz explains, how Europe could lead the quantum computing industry.

Find out more

Forbes - Sun, 29. December 2019

The Best Machine Learning Startups to Work For In 2020 Based On Glassdoor

US business magazine „Forbes“ counts KONUX among the 15 best startups to work for in the field of machine learning. KONUX is a MIG portfolio company.

Find out more

FAZ - Wed, 18. December 2019

People of the Year

„Frankfurter Allgemeine Zeitung“ calls Ugur Sahin, CEO of BioNTech, a MIG portfolio company, to the people of the year 2019.

Find out more

Handelsblatt - Wed, 13. November 2019

Europe has to achieve a leading role in Quantum Computing

Dr. Jan Goetz, CEO of IQM, explains in a by line article in „Handelsblatt.com“, why Europa beside the USA and China should participate in the race for the first scalable Quantum Computer. IQM is a leading European Quantum Computing Start-up and a MIG portfolio company.

Find out more

Nature - Mon, 21. October 2019

Injection of hope

Leading scientific magazine „Nature“ shows in an article the example of a cancer patient, who achieves with individual RNA-based vaccine from BioNTech, a MIG portfolio company, striking results.

Find out more

Handelsblatt - Mon, 14. October 2019

Biontech-CEO Sahin explains, what the IPO is changing

German business newspaper „Handelsblatt“ honors the significance of the IPO of Biontech, a MIG portfolio company, for the Biotech sector of Germany.

Find out more

Munich Startup - Fri, 11. October 2019

Konux starts international projects

The platform „Munich Startup“ describes how MIG portfolio company Konux internationalizes the business.

Find out more

Handelsblatt, Going Public, Transkript - Thu, 10. October 2019

IPO of BioNTech

Several media report about the IPO of BioNTech at Nasdaq, New York.

Find out more

FAZ - Thu, 10. October 2019

Biontech aquires less money as expected

German newspaper „FAZ“ reports about the IPO of Biontech at Nasdaq. The valuation of the MIG portfolio company was 3.4 Billion US Dollar

Find out more

Wallstreet-online - Tue, 24. September 2019

FutureCarbon presents a new system of infrared heating

An announcement informs about a new product of FutureCarbon, a MIG portfolio company.

Find out more

Handelsblatt - Wed, 04. September 2019

Bill and Melinda Gates invest in German biotech firm BioNTech

"Handelsblatt" reports about a 50 million Euro donation of Gates foundation to BioNTech to develop vaccines against HIV and tuberculosis. BioNTech is a MIG portfolio company.

Find out more

Handelsblatt - Wed, 28. August 2019

Biotech-firm Immatics closes a Billion-Deal with Celgene

Business newspaper „Handelsblatt“ reports about a new cooperation of Immatics. The article names MIG Fonds as a VC-Investor of Immatics.

Find out more

Wirtschaftswoche - Wed, 24. July 2019

GWA Hygiene acquires HyHelp

The founders platform of „Wirtschaftswoche“ reports about the acquisition of Hyhelp by MIG portfolio company GWA Hygiene.

Find out more

Ostsee-Zeitung - Thu, 11. July 2019

Top-Deal for Start-up of Stralsund

Regional newspaper „Ostsee-Zeitung“ reports about a cooperation between MIG portfolio company GWA Hygiene and big pharma B. Braun Melsungen, which drives internationalization of GWA.

Find out more

Manager Magazin Online, FAZ.net - Tue, 09. July 2019

BioNTech: Company from Mainz collects 325 Millionen Dollar

Several media report a financing round of BioNTech, a MIG portfolio company, of 325 Millionen Dollar, one of the largest single financing rounds of a private owned european biotech firm ever.

Find out more

Finanzwelt, Wirtschaftswoche Online - Tue, 09. July 2019

MIG Fonds invest in Finnish Start-up

Some national und international media report about the new investment of MIG Fonds in IQM, a Finnish start-up focusing on quanten computing.

Find out more

Handelsblatt - Sat, 01. June 2019

An Oil Firm turns to a Plastic Disposal Company

„Handelsblatt“ describes the transformation of MOL, the largest private owned company in Ungary, which fosters strongly the business of plastic disposal in cooperation with APK, a MIG portfolio company.

Find out more

„Crunchbase“, „Display Daily“ - Tue, 14. May 2019

OLED Materials Innovator CYNORA Secures US$25M in First Closing of Series C Round.

„Crunchbase“, „Display Daily“ and other US-Trade Magazines report about a successful 25 Mio. US Dollar Series C Round of CYNORA. MIG Fonds participated in further financing of the portfolio company.

Find out more

Finanzwelt - Thu, 02. May 2019

„We achieved some highlights in 2018“

„Finanzwelt“ reports about MIG AGs fiscal year 2018.

Find out more

Bioökonomie.de - Thu, 02. May 2019

Givaudan buys Cosmetics of AMSilk

A trade magazine informs about the sale of the cosmetic business of Amsilk, a MIG portfolio company, to the world largest producer of perfume and flavours.

Find out more

KfW-Stories - Tue, 09. April 2019

Protection against Hospital Germs

An online-magazine of Kreditanstalt für Wiederaufbau (KfW) describes the business model of GWA, a MIG portfolio company.

Find out more

Handelsblatt - Tue, 09. April 2019

In Search for a Biotope

The article describe the landscape of German biotech firms and mention MIG Fonds as an important investor.

Süddeutsche Zeitung - Sun, 31. March 2019

About Spiders

German newspaper „Süddeutsche Zeitung“ reports about the different kinds of spiders and spider webs. Because the demand of silk is constantly increasing, the article although describes the activities of MIG-portfolio company Amsilk, which produces artificial silk.

Find out more

DS deutsche startups, Finanzwelt - Fri, 15. March 2019

MIG Fonds invest in Denmark

Several media report about MIG Fonds newest investment in Danish platform Liva Healthcare.

Find out more

Going Public Media - Fri, 22. February 2019

Affiris collects 10 Mio. EUR in financing round

A trade magazine informs about a financing round of MIG portfolio company Affiris, Vienna, in which MIG Fonds are participating.

Find out more

ZDF - Thu, 14. February 2019

Well founded

In a TV-report of „ZDF“ about the European start-up landscape altough NaVvis is mentioned, a MIG portfolio company.

Find out more

Gründerszene - Wed, 13. February 2019

Alibabas surprising investment in Konux

„Gründerszene“ informs about Alibabas investment in Konux, a MIG portfolio company.

Find out more

Der SPIEGEL - Sat, 26. January 2019

The dilemma of success

„DER SPIEGEL“ portrayed over the last years „champions of tomorrow“ and reports now about their development. Among the start-ups are NaVvis and BioNTech, two MIG portfolio companies.

Handelsblatt - Thu, 24. January 2019

German Start-up presents bracelet from artifcial spider silk

„Handelsblatt“ reports about a product innovation of Amsilk, a MIG portfolio company.

Find out more

Handelsblatt - Fri, 04. January 2019

Another Big Pharma invests in German Biotech-Star

Beside other media „Handelsblatt“ reports about a 80 Millionen Euro investment of Sanofi in BioNTech, a MIG portfolio company.

Find out more

Digital Business - Sat, 15. December 2018

Success in Venture Capital Business

Michael Motschmann, General Partner of MIG AG, explains the German landscape of financing start-ups.

Find out more

VC Magazin, Wirtschaftswoche und Gründerszene - Mon, 10. December 2018

NavVis: The Indoor Street View receives 31 Millionen Euro

Several Media reports about a series C financing round of NaVis. MIG Fonds are participating and increase their shares.

Find out more

Enterprise Management 360 Grad - Mon, 26. November 2018

Top 10 IoT Companies rocking your socks off

Platform „Enterprise Management 360 Grad“ elaborates a ranking of most innovative IoT firms, which names beside of Hitachi, Verizon and Huawei although Konux and NavVis, both MIG portfolio companies.

Find out more

Börsen-Zeitung - Fri, 16. November 2018

MIG with various IPO-Options

Michael Motschmann, General Partner of MIG AG, explains in „Börsen-Zeitung“ the business modell and perspectives of MIG.

Find out more

Handelsblatt - Tue, 13. November 2018

The third Life

„Handelsblatt“ reports about the onboarding of Volker Kefer, a ex Member of Board of Deutsche Bahn, at Konux, a MIG portfolio company.

Find out more

FAZ - Tue, 13. November 2018

Infineon buys technology of the future

Leading newspaper „FAZ“ reports about the acquisition of Siltectra by Infineon and indicates MIG Fonds as main VC investor.

Handelsblatt - Mon, 12. November 2018

Infineon buys Start-up from Dresden for 124 Mill. Euro

„Handelsblatt.com“ reports about the recent exit of MIG Fonds.

Find out more

Handelsblatt, Frankfurter Allgemeine Zeitung - Tue, 06. November 2018

New vaccine as purpose

The newspapers „FAZ“ and „Handelsblatt“ report about a new approach of BioNTech, a MIG-portfolio comany, to develop a new vaccine against infectious diseases partnering with an US-University.

Find out more

FAZ - Tue, 06. November 2018

Frontrunner of personalized medicine

Newspaper „FAZ“ portrays BioNTech as pionier of a new medicine against cancer. MIG Fonds are named as one of the first investors.

Compound Semiconductor - Fri, 05. October 2018

Siltectra Ramps Up Wafering Services

Trade Magazin „Compound Semiconductor“ reports about a new outsourcing wafering service of Siltectra, a MIG portfolio company and disruptive innovator in Cold Split wafering.

Find out more

Life Science - Sat, 15. September 2018

We create the companies of the next decades

Michael Motschmann, General Partner MIG AG, and Dr. Helmut Jeggle, MD Athos Service GmbH (Family Office Strüngmann) explain in a common interview the future of German biotechnology.

Find out more

Süddeutsche Zeitung - Tue, 11. September 2018

Aircrafts hanging on a silk thread

„Süddeutsche Zeitung“ reports about a cooperation between Airbus Group and Amsilk, a MIG portfolio company, in terms of new materials based on Amsilks technology.

Find out more

Handelsblatt - Tue, 11. September 2018

Biotechfirma Immatics will mit Krebstherapien zum Einhorn werden

„Handelsblatt.com“ reports about the progress of Immatics, a MIG portfolio company, with cancer therapy and describes possible IPO plans.

Find out more

Capital - Mon, 27. August 2018

High expectations

Business Magazin "Capital" describes the business model and the perspectives of BioNTech, a MIG portfolio company

FAZ - Sun, 19. August 2018

Millions for the fight against flu

The regional Rhein-Main edition of „FAZ“ reports about new developments of BioNTech, a MIG portfolio company

Mehr erfahren

Handelsblatt / Frankfurter Allgemeine Zeitung / Spiegel Online - Thu, 16. August 2018

BioNTech gets Pfizer as partner

„Handelsblatt“, „FAZ“ and „Spiegel Online“ report about a cooperation between Pfizer and BioNTech, a MIG portfolio company.

Find out more

Wirtschaftswoche - Mon, 13. August 2018

GWA Hygiene, 2,5 million Euro for digital inspection

„Wirtschaftwoche Online“ reports about the entry of MIG Fonds with start-up GWA Hygiene

Find out more

Finanzwelt - Fri, 10. August 2018

MIG-Fonds invest in better hospital hygiene

„Finanzwelt“ reports about the new MIG portfolio company GWA Hygiene.

Find out more

Handelsblatt - Fri, 10. August 2018

Millions for GWA Hygiene

„Handelsblatt“ covers the financing round of start-up GWA Hygiene with participation of MIG-Fonds.

Finanzwelt - Thu, 26. July 2018

MIG with investment in new portfolio company

Die „Finanzwelt“ berichtet über den Einstieg der MIG in ein weiteres Beteiligungsunternehmen.

Find out more

transkript - Thu, 12. July 2018

Immatics convinces Genmab with own antibodies

Trade magazine „transcript“ reports about the cooperation between Immatics, a MIG portfolio company, with Europes biggest biotech-enterprise.

Find out more

FAZ - Sun, 24. June 2018

How two start-ups fight against plastic waste

„FAZ“ describes the business models of two start-ups recycling plastic, among them the disruptive approach of APK, a MIG portfolio company.

cogX - Tue, 19. June 2018

Konux receives cogX Award

MIG portfolio company Konux receives in London prestigious cogX Award..

Find out more

Economist - Mon, 18. June 2018

A new breed of German Start-ups

British „Economist“ describes the booming German start-up scene and focus although on Konux and NavVis, two MIG portfolio companies.

Find out more

Wirtschaftswoche - Sat, 16. June 2018

We introduce robotic to construction sites

Kewazo, a new MIG portfolio company, presents in the „elevator pitch“ of „Wirtschaftswoche“ its business model.

Find out more

Focus - Sat, 26. May 2018

The Biontech-Wonder of Mainz

Newsmagazine „Focus“ dedicate a signature article to the development of BioNTech, a MIG portfolio company

Mitteldeutsche Zeitung - Wed, 23. May 2018

Just gotta save the world real quick

„Mitteldeutsche Zeitung“ explains the new disruptive method of APK, a MIG-Portfolio company, recycling packaging waste into synthetic material.

Find out more

Süddeutsche Zeitung - Thu, 17. May 2018

Money for new ideas

„Süddeutsche Zeitung“ explains based on case study KEWAZO, a portfolio company of MIG Fonds, how financing of a start-up is working and calls MIG a leading German Venture Capital Investor

Find out more

Finanzwelt - Wed, 16. May 2018

MIG Fonds secure financing of clinical surveys

„Finanzwelt“ reports about a financing round of MIG with several Co-Investors of 6 Millionen Euro to Biotech Start-up advancedCOR.

Find out more

Wirtschaftswoche - Fri, 11. May 2018

NFON with a successful IPO

„Wirtschaftswoche“ among several media reports about the successful IPO of NFON, a MIG- portfolio company.

Find out more

Finanzwelt, VC Magazin - Thu, 26. April 2018

MIG Fonds invest in new Start.up

„Finanzwelt“ and „VC Magazin“ report about the new investment of MIG in start-up KEWAZO.

Find out more

FAZ, Gruenderszene, Wiwo.de - Sat, 21. April 2018

Further Investment Konux

Several media report about the participation of MIG Fonds of 5 million US-Dollar in a Series B financing round of Konux, a portfolio company of MIG Fonds.

Find out more

VC Magazin - Sun, 15. April 2018

Interview with Michael Motschmann

In a discussion with „Venture Capital Magazin“ Michael Motschmann, General Partner of MIG AG, point out the relevance of a performing capital market for young companies.

Find out more

Handelsblatt - Wed, 04. April 2018

NFON is preparing an IPO

Cloud telephony provider NFON announces plans for an IPO. Two MIG Fonds are holding shares of together 13,3 percent of NFON.

Find out more

Nordbayerischer Kurier - Wed, 21. March 2018

Wallpainting as heater

The regional newspaper „Nordbayerischer Kurier“ describes the business model of FutureCarbon, a portfolio company of MIG Fonds.

Find out more

Semiconductor Today/Solid State Technology - Mon, 26. February 2018

News about Siltectra

Trade Magazines report, that Siltectra, a portfolio company of MIG Fonds, succeed with a technological breakthrough. The start-up from Dresden splits wafers with it´s so called twinning method and helps to cut costs for manufacturers.

Semiconductor Today: Find out more

Solid State Technology: Find out more

transkript - Thu, 15. February 2018

On the road to routine diagnostics

The trade magazine „transkript“ portrays in detail Biocrates, a portfolio company of MIG Fonds, and highlights the extraordinary potential of this start-up.

Labor Journal - Tue, 23. January 2018

Double success for hunters of metabolites

Trade magazine „Labor Journal“ explains the recent strategic progresses of Biocrates, a portfolio company of MIG Fonds.

Find out more

Finanzwelt - Tue, 23. January 2018

MIG AG continues course for success

Report about the fiscal year 2017 of MIG AG

Find out more

World Economic Forum (WEF) - Thu, 18. January 2018

Konux awarded as one of 30 global „Technology Pioneers“

WEF/Davos has nominated Konux, a portfolio company of MIG Fonds, as one of the most innovative start-ups – beside Google, Dropbox and Twitter.

Find more out

DIE WELT - Wed, 17. January 2018

The most exiting innovations in Germany

In an interview with „WELT“ Prof. Dr. Joachim Henkel, chair owner for innovation research of TU Munich, designates Konux and Navvis, two portfolio companies of MIG Fonds, as outstanding start-ups.

Find out more

Handelsblatt - Thu, 04. January 2018

US Investors bet on German Biotech-Unicorn

„Handelsblatt“ reports about fundraising of BioNTech, a portfolio company of MIG Fonds, and explains how the firm will invest the 270 million $.

Find out more

Reuters - Thu, 04. January 2018

Europe´s biggest private biotech company raises $270 million

The news agency „Reuters“ reports about funding of $270 million by BioNTech, a portfolio company of MIG Fonds.

Find out more

transkript - Wed, 03. January 2018

Biocrates takes over Metanomics

Trade magazine „transcript“ reports about the acquisition of Metanomics by Biocrates, a portfolio company of MIG Fonds. BASF Plant Services, the former owner of Metanomics, is now a minor stakeholder of Biocrates.

Find out more

FAZ - Thu, 14. December 2017

More space for the fight against cancer

A regional edition (Rhein-Main) of „Frankfurter Allgemeine Zeitung“ describes the work and progresses of Biontech, a portfolio company of MIG Fonds.

Find out more

Spiegel Wissen Extra - Mon, 27. November 2017

Injection instead of scalpel

„Spiegel Wissen“ explains the state of the art of the research respect to the injection against cancer. In the center of the article is the work of Prof. Dr. Ugur Sahin, CEO of BioNTech, a portfolio company of MIG Fonds.

Global Investor - Wed, 22. November 2017

Growth Engine Venture Capital

Michael Motschmann, Member of the Board and Venture Partner of MIG AG, explains in a byline article, why Venture Capital is so important for the future of the German economy.

Venture Capital Magazin - Wed, 01. November 2017

Disruptive Technology in Display Industry

„Venture Capital Magazin“ reports about the progress of CYNORA, a portfolio company of MIG Fonds. MIG AG Venture Partner Dr. Axel Thierauf explains the perspectives of CYNORA.

Find out more

Frankfurter Allgemeine Sonntagszeitung - Sun, 22. October 2017

Vaccination against Cancer

The article explains the progress in the fight against cancer and spotlights the success of BioNTech, a portfolio company of MIG Fonds.

Find out more

FinanzNachrichten.de - Fri, 13. October 2017

RAC Cooling Industry Award 2017

Efficient Energy, a portfolio company of MIG Fonds, scooped a well-respected award of the refrigeration technology sector for its innovative generation eChillern

Find out more

Focus Online - Sun, 08. October 2017

Will this scientist find the magic bullet versus cancer?

„Focus“ about the progress on individualized cancer immunotherapy with spot on the work of Ugur Sahin, CEO of BioNTech, a portfolio company of MIG Fonds.

Business Wire - Thu, 14. September 2017

LG und Samsung investieren 25 Millionen Euro in Cynora

An article about LG and Samsung, two Korean global corporations, to share in Cynora

Find out more

DIE WELT - Tue, 22. August 2017

Cobwebs can improve breast implants

„Die Welt“ about technological progress at AmSilk, a portfolio company of MIG Fonds

Find out more

BNN - Thu, 03. August 2017

Search for the perfect blue

In its serial „Secret Stars“ of regional economy „BNN“ portrays Cynora, a MIG Fonds portfolio company.

FAZ - Mon, 31. July 2017

A cool madness

„Frankfurter Allgemeine Zeitung“ about the invention of the founders of Efficient Energy, a portfolio company of MIG Fonds.

FAZ - Tue, 25. July 2017

To fight cancer with vaccines

A detailed article of „Frankfurter Allgemeine Zeitung“ about approach and prospects of BioNTech to defeat cancer

Find out more

Finanzwelt - Mon, 17. July 2017

MIG Fonds distribute ca. 90 Mio. EUR

„Finanzwelt“ takes up a press release of MIG AG, that MIG Fonds in the first half-year 2017 invested ca. 25 Mio. EUR in 16 portfolio companies and distributed ca. 64 Mio EUR to private investors.

Find out more

Der SPIEGEL - Sat, 08. July 2017

Each to his own medicine

„Der Spiegel“ with a detailed profile about the previous track record of BioNTech, a portfolio company of MIG Fonds.

Find out more

Handelsblatt - Thu, 06. July 2017

To vaccinate against cancer

„Handelsblatt“ informs about the recent advances of BioNTech to fight cancer and mention MIG Fonds as investors.

Find out more

Handelsblatt - Wed, 05. July 2017

Spider silk without spiders

„Handelsblatt“ describes in detail on technology and application of AMSilk, MIG Fonds are mentioned as investors

Find out more

Handelsblatt - Mon, 19. June 2017

Fresh colours for displays

A detailed article in „Handelsblatt“ comments on the business model of Cynora and mentions IPO-plans of the management for 2019 in USA. MIG Fonds are emntioned as investors.

Find out more

World Economic Forum, Juni 2017 - Thu, 15. June 2017

Konux receives award “Technology Pioneer 2017”

The respected World Economic Forum (WEF) recently presented a list oft he worlds most innovatiye companies, among them also Konux.

Find out more

BILANZ - Fri, 26. May 2017

Here Start-ups get more than just a cash injection

The trade journal „Bilanz“ presents the 20 main venture capitalists in Germany, among them Michael Motschmann, general partner of MIG AG.

Find out more

Frankfurter Allgemeine Sonntagszeitung - Sun, 14. May 2017

We are close to defeat cancer

In an interview with „Frankfurter Allgemeine Sonntagszeitung“ comments Thomas Strüngmann on his investment strategiy and points detailed to BioNTech. Beside the Family Office of the brothers Strüngmann also MIG Fonds are shareholders of this Biotech company.

FAZ - Sun, 30. April 2017

„A shoe made of silk“

„Frankfurter Allgemeine Sonntagszeitung“ illustrates the innovative technology of AmSilk, a portfolio company of MIG Fonds, and its application in textile industry. It is also reported about the chance how the synthetic silk done by AMSilk could resurrect the german textile industry.

Find out more

Handelsblatt - Wed, 19. April 2017

Clever Track, alert Track Switch

An article of „Handelsblatt“ about how Deutsche Bahn, amongst others suppported by the Start-up Konux, wants to avoid delays and cancellations.

Find out more

Handelsblatt - Thu, 06. April 2017

America‘s Favourite

„Handelsblatt“ with a portrait of Konux

Find out more

Handelsblatt - Fri, 31. March 2017

Awarded Start-ups

„Handelsblatt“ annually awards the digital prize „The Spark“. As a finalist of previous year Konux, a portfolio company of MIG Fonds, presented its business model.

Find out more

Handelsblatt - Fri, 17. March 2017

"Deutschlands 100 klügste Köpfe" (Germany’s 100 masterminds)

„Handelsblatt“ has awarded „Deutschlands 100 klügste Köpfe“. Holger Sedlak (Efficient Energy), Georg Schroth (Navvis) und Prof. Dr. Ugur Sahin (Biontech) belong to these 100 innovators. We proudly congratulate the founders of our portfolio companies on this success.

Find out more

Finanzwelt - Mon, 13. March 2017

The next exit

Finanzwelt addresses MIG Fonds‘ next exit

Find out more

Süddeutsche Zeitung - Wed, 22. February 2017

Like silk

In a detailed article Süddeutsche Zeitung presents technology and business model of AMSilk GmbH (portfolio company of MIG Fonds)

Find out more

Laborpraxis - Wed, 15. February 2017

Targeted Metabolomics

The scientific journal „Laborpraxis“ characterizes in a three-pager the use of Biocrates-kits for detections of individual health status. Biocrates is a portfolio company oft he MIG Fonds.

Börsen-Zeitung - Fri, 10. February 2017

MIG Fonds cash in on Brain

Börsen Zeitung talks about MIG Fonds and Brain AG – involvement and exit in progress

Find out more

Der SPIEGEL - Sat, 28. January 2017

The data vacuum

In a series of articles on the “Champions of Tomorrow”, der SPIEGEL presents NavVis GmbH, a portfolio company of MIG Fonds.

FAZ - Mon, 16. January 2017

“Investment company MIG awakens stock exchange fantasies”

In a discussion with the Frankfurter Allgemeine Zeitung, Michael Motschmann, General Partner and member of the Executive Board at MIG AG, explains what plans the VC investors of MIG Verwaltungs AG have in store.

Capital Heft Dezember - Tue, 06. December 2016

Top 40 under 40

The economic journal “Capital” runs a cover story on Germany’s young elite featuring Andreas Kunze, CEO of MIG portfolio company Konux.

Süddeutsche Zeitung - Wed, 16. November 2016

Funds for founders

Michael Motschmann, General Partner and member of the Executive Board at MIG AG, is quoted several times in an article by the Süddeutsche Zeitung on the funding options for start-up companies.

Handelsblatt - Wed, 02. November 2016

German biotechnology: foreign companies want in

The Handelsblatt has published an article shedding some light on the sale of MIG portfolio company Ganymed to Japanese pharmaceutical company Astellas. MIG is named as the venture capitalist.

Handelsblatt - Tue, 01. November 2016

Digital prize "The Spark" – More guts will do you good

Handelsblatt and McKinsey have awarded Konus and NaVvis, two portfolio companies of MIG Fonds, with the digital prize “The Spark” for innovations in industry 4.0.

Find out more

Euro am Sonntag - Sun, 09. October 2016

We’re at the beginning of an era

Jürgen Eck, CEO of BRAIN AG, a MIG portfolio company, explains why he believes the trend for natural solutions in the chemical and consumer goods industry will keep on growing and growing.

Handelsblatt - Sat, 01. October 2016

Efficient Energy - cool stuff

Handelsblatt presents Efficient Energy, a MIG portfolio company, and describes their new refrigeration technology as an innovative breakthrough. MIG Fonds are named as venture capitalists.

Find out more

F.A.S. - Sun, 25. September 2016

Millions from California for the biotech pioneers from Mainz

Frankfurter Allgemeine Sonntagszeitung publishes an article about partnership between BioNTech, a MIG portfolio company, and the pharmaceutical company Genentech. Genentech has made an upfront payment of 310 million dollars to BioNTech.

Fierce Biotech - Wed, 21. September 2016

Genentech lays $310M wager on BioNTech’s mRNA cancer vaccine platform

The trade journal FierceBiotech outlines the newest deal involving the payment of 310 million USD to MIG portfolio company BioNTech from Roche’s affiliated company Genentech.

Find out more

EP Vantage - Wed, 21. September 2016

Biontech deal sees Roche bet on mRNA

The article by EP Vantage covers the latest partnership entered into by MIG portfolio company BioNTech aiming to advance developments of mRNA-based cancer vaccines. The pharmaceutical group Roche is also in on the latest deal.

Find out more

VC Magazin - Wed, 31. August 2016

Interview with Michael Motschmann and Dr. Matthias Kromayer

The two MIG AG Executive Board members comment to recent successful exits, flotation of MIG portfolio company BRAIN and their next strategical moves with Venture Capital Magazin.

Harvard Business Manager - Tue, 30. August 2016

Inspiration in instalments

For a case study conducted by Harvard Business Manager, Dr. Matthias Kromayer, member of the Executive Board at MIG AG, discusses three principles of strategic company management.

Frankfurter Allgemeine Sonntagszeitung - Sun, 21. August 2016

The dream team of the biotech industry

Frankfurter Allgemeine Sonntagszeitung presents Özlem Türeci and Ugur Sahin, CEOs of Ganymed and BioNTech respectively. Both companies belong to the MIG portfolio.

Süddeutsche Zeitung - Fri, 22. July 2016

Playing with your own money “kills your ego”

Profile of the MIG portfolio company Konux and its co-founder Andreas Kunze.

Find out more

Fierce Biotech - Sun, 05. June 2016

Billionaire-backed Ganymed grabs ASCO spotlight

The renowned trade journal FierceBiotech reports on ASCO, the largest oncology congress in the world. MIG portfolio company Ganymed is one of the stars of the show with their new phase 2b trial.

Find out more

Wirtschaftswoche - Wed, 01. June 2016

First universal cancer vaccine within reach

The article outlines MIG portfolio company BioNTech’s ground-breaking progress in the fight against cancer.

Find out more

FAZ - Mon, 23. May 2016

Off through the museum with a ‘data hoover’

FAZ has published a detailed article discussing how the 3D trolley developed by NavVis, an MIG portfolio company, captures and maps interior spaces.

Find out more

Handelsblatt - Fri, 29. April 2016

Start-up company Konux – the defect detector

Smart sensors and prominent investors: MIG portfolio company Konux wants to revolutionise the untended German industry by helping to eliminate faults before they even occur.

Find out more

Finanzwelt - Fri, 15. April 2016

An addition to the MIG Fonds portfolio

Finanzwelt talks about MIG Fonds‘ acquisition of a 16.26 % share in Konux Inc in a series A round, making Konux the youngest company in MIG’s portfolio.

Find out more

Focus Online - Mon, 11. April 2016

China stumps up billions for German entrepreneurs

Heinrich von Pierer describes the latest trend, whereby Chinese sovereign wealth funds are ending up in Germany as venture capitalist funds – a development which can even create opportunities for MIG.

Find out more

Handelsblatt - Wed, 16. March 2016

Cancer vaccines

Handelsblatt presents Biontech as an inspiring start-up business in the biotech sector in a full-page profile, making several references to MIG Fonds as the participating VC investor.

Süddeutsche Zeitung - Thu, 03. March 2016

One number, a worldwide connection

SZ features an article outlining the wide-reaching scope of the collaboration between Nfon, an MIG portfolio company, and German Telekom in developing cloud-based telephone systems.

Find out more

Manager Magazin - Tue, 23. February 2016

A new Germany

NavVis, an MIG portfolio company, took pride of place as one of the hidden champions in an article listing over 50 successful digital business models.

Find out more

Handelsblatt - Wed, 27. January 2016

Indoor satnavs

Handelsblatt has published an extensive profile on NavVis, citing MIG AG as a key VC investor who has been channeling money into the up-and-coming business since 2014.

Börsen-Zeitung - Fri, 22. January 2016

Brain risks IPO despite the storm raging on the stock market

The response to being given the go-ahead for an IPO was obviously so good that the biotech firm Brain wants to follow through with its first steps onto the capital market despite the storm that’s currently raging.

Focus Online - Tue, 19. January 2016

Technological company Brain goes public

Dr. Heinrich von Pierer has written an article explaining what consequences the IPO of Brain AG, an MIG Fonds portfolio company, will have for the German start-up business scene.

Find out more

DLD - Mon, 18. January 2016

Jury awards top-class prize to NavVis

This year, the internationally renowned DLD prize “Digital Star” goes to NavVis, an MIG Fonds portfolio company. The start-up company from Munich won the main prize entitled “Innovation of the Year”.

Börsen-Zeitung - Wed, 06. January 2016

When Microorganisms solve problems

Börsen-Zeitung sheds some light on Brain AG’s business model, as well as their plans for the stock market. The article names MIG as an essential investor.

MIG - Press Review

„Münchner Merkur“ portrays NavVis, a MIG-portfolio company.

A podcast of „Manager Magazin“ explains the state of the art of Quantum Computing and mentions MIG portfolio company IQM as a leading player and Michael Motschmann, General Partner MIG AG, as investor.

„Manager Magazin Online“ reports about the assignment of Helmut Jeggle as Member of the Supervisory Board of IQM. The article mentions MIG Fonds and Michael Motschmann, Gneneral Partner of MIG AG, as first investor of the Finnish-German Start-up in Quantum Computing.

Super Quanten

„Süddeutsche Zeitung“ reports about an innovative Quantum Computing Project of Leibnitz Rechenzentrum (LRZ) in Garching/Munich integrating IQM, a MIG portfolio company.

„Investors got their money seven times back“

Interview with Michael Motschmann, General Partner of MIG AG, in „VC-Magazin“ about the investment in BioNTech

In an article about the German Biotech Industry „Manager Magazin“ quotes Dr. Matthias Kromayer, General Partner of MIG AG.

„What in Germany is possible“ and „The Heroes of the German Vaccine Fairy Tale“

„DIE WELT“ describes the development of MIG portfolio company BioNTech und the founders. The article refers to the role of Michael Motschmann and Dr. Matthias Kromayer, General Partner of MIG AG. Additionally an interview in „DIE WELT“ with Michael Motschmann.

Six Start-ups are the German Hope in Quantum Computing

„Handelsblatt“ mentions IQM, a MIG portfolio company, as one of the leading German start-ups in Quantum Computing

Success with molecules

In an article about Biotech IPOs in the US, „Börse Online“ quotes Dr. Matthias Kromayer, General Partner MIG AG.

The next enemy will be tougher

„Wirtschaftswoche“ explains the future of MIG portfolio company BioNTech with quotes of Michael Motschmann, General Partner MIG AG.

Serious deficits

Angela Merkel and other heads of government claim a digital pact. Dr. Jan Goetz, CEO of MIG portfolio company IQM, calls for an European approach to Quantum Computing.

The dark of COVID-19 brings promise to Germany´s biotech scene

Trade publication „BioCentury“ quotes Michael Motschmann, General Partner of MIG AG, in an article about the future of German Biotech industry.

Many ideas, little money

„tagesschau.de“ reports about investments in Biotech in Germany and quotes Michael Motschmann, General Partner MIG AG.

Next MIG Invest in Medical Technology

Several Trade Magazines report about MIGs investment in new portfolio company Creative Balloons.

The Deals of German Biotech Investors

Trade Magazin „CHEManager“ reports about German Investors in Biotech, among them MIGs investments.

Record return for MIG because of Biontech

„Börsen Zeitung“ interviews Michael Motschmann, General Partner of MIG AG, about new developments at MIG

MIG Fonds expand in the French Alps

„Finanzwelt“ reports about a new investment of MIG Fonds in Zadient Technologies.

BioNTech Fund (MIG) pays 600m Euro dividend on back of vaccine success

International and national media among them „Financial Times“ and „Reuters“ report about the record payment of MIG Fonds of 600m Euro to investors.

„Manager Magazin“ interviews Michael Motschmann, General Partner of MIG AG, and Co-Investors Thomas Strüngmann and Helmut Jeggle about their joint involvement at BioNTech SE.

Exosceletts reduce sick days

„Handelsblatt“ reports about the technology of GBS, a start-up producing exosceletts; MIG Fonds invested recently.

Screen Supplier to sell

„FAZ“ reports about the start of a trade sale of Cynora, a portfolio company of MIG Fonds.

Express

„Süddeutsche Zeitung“ describes how BioNTech developed in a very short period the vaccine against Covid-19 and marks Michael Motschmann, General Partner of MIG AG, as one of the first investors of BioNTech.

FT People of the Year: BioNTech´s Ugur Sahin and Özlem Türeci

„Financial Times“ chooses BioNTech´s Ugur Sahin and Özlem Türeci as „People of the Year“. In a cover story MIG AG is described as a first investor and Matthias Kromayer, General Partner of MIG AG, is quoted.

German Bionic raises $20 M led by Samsung for exoskeleton tech to supercharge human labor

„Techcrunch“ and other media report about a Series A-Financing of German Bionic Systems by MIG Fonds and other investors.

Bloomberg prognosis, 13. Dezember 2020, First Covid Vaccines´ Triumph Raises Hope for Cancer Fight

„Bloomberg prognosis“ explains how mRNA vaccines against Covid-19 raises hope in the fight against cancer, with quotes of Dr. Matthias Kromayer, General Partner of MIG AG.

The couple behind the vaccine against Covid-19

„Tagesschau.de“ portrays Özlem Türeci and Ugur Sahin, the founder of MIG-portfolio company BioNTech, and quotes Michael Motschmann, General Partner of MIG AG.

From Biontech to Sputnik V

Dr. Matthias Kromayer, General Partner MIG AG, explains in a byline article for „Handelsblatt“ the differencies between the vaccines against Covid-19.

Start-up Konux gets a large order from Deutsche Bahn

„Handelsblatt“ reports about a large order of Deutsche Bahn to Konux, a MIG Portfolio company.

Competition for the Super-Brain

„Bayerische Staatszeitung“ explains the development of Quantum Computing and reports about IQM, a MIG portfoliocompany.

Great Britain approves vaccine of Biontech and Pfizer against Covid 19

Like other media around the globe „FAZ“ reports about the first approval of Biontechs vaccine against Covid-19.

MIG Fonds invests in Innatera

Several Media report about investment of MIG Fonds in new portfolio company Innatera

Application for admission of Corona vaccine submitted

„DIE ZEIT“ reports like many other media around the globe that MIG portfolio company BioNTech together with Pfizer submitted the application for admission of their Covid-19 vaccine at FDA .

The Billionaires behind the Vaccine

„FAS“ describes the engagement of BioNTech investors Andreas and Thomas Strüngmann and the role of Michael Motschmann, General Partner of MIG AG, financing the firm from Mainz.

„Never in my career I met such a brilliant couple“

Michael Motschmann, General Partner of MIG AG, and Thomas Strüngmann explain in an interview with „Süddeutsche Zeitung“ their relationship as investors to BioNTech founders Prof. Dr. Ugur Sahin and Özlem Türeci.

Founder couple from Mainz develops vaccine against corona

In a title story „Handelsblatt“ portrays the founder of BioNTech und mentions the role of Michael Motschmann, General Partner of MIG AG, as first investor

IQM Hope in Quantum Computing

German business newspaper „Handelsblatt“ portrays MIG portfolio company IQM in a comprehensive article as hope of the European Quantum Computing Industry.

Vaccine milestone heralds „normal life“ by next spring

The breaking news about important steps toward a vaccine against Covid-19 causes, that newspapers around the world like „The Times“ report about the founders of BioNTech, a MIG portfolio company, on their frontpages.

MIG Fonds lead financing round at IQM

Several media report a 36 Mio. Euro financing round at IQM Quantum Computing led by MIG Fonds.

The Start-up of Gloria Seibert shaped the market in an early stage

„Handelsblatt“ explains in a comprehensive article the business model of Temedica and mentions MIG Fonds as investor.

Behind Pfizer´s vaccine, an understated husband-and-wife „dream team"

Newswire „Reuters“ is portraying the couple behind BioNTech with quotes of Dr. Matthias Kromayer, General Partner MIG AG and for many years member of the supervisory board of BioNTech.

Corona-Vaccine of BioNTech effective in over 90 percent of cases

MIG-portfolio company BioNTech und partner Pfizer are announcing important improvements of their vaccine against Covid-19. Media around the world are reporting, among them „FAZ“.

If the digital consultant cares about your finance

reports about digital platforms in the finance industry and mentions wealthpilot, a MIG portfolio company.